UPDATE -- American Health Council Names Top Ten Nursing Schools for 2017
May 22, 2017 20:12 pm UTC| Business
NEW YORK, May 22, 2017 -- According to the U.S. Bureau of Labor Statistics, an estimated 500,000 registered nurses are expected to retire by 2022. To prevent a shortage of nurses in the healthcare field, the U.S. Bureau...
Elite Pharmaceuticals Acquires Trimipramine ANDA
May 22, 2017 20:12 pm UTC| Business
NORTHVALE, N.J., May 22, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), today announced the acquisition of an approved and currently marketed Abbreviated New Drug Application (“ANDA”) for...
Elite Pharmaceuticals Acquires Trimipramine ANDA
May 22, 2017 20:12 pm UTC| Business
NORTHVALE, N.J., May 22, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), today announced the acquisition of an approved and currently marketed Abbreviated New Drug Application (“ANDA”) for...
CareDx Reports Preliminary First Quarter 2017 Financial Results
May 22, 2017 20:10 pm UTC| Business
BRISBANE, Calif., May 22, 2017 -- CareDx, Inc.(Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for...
CareDx Reports Preliminary First Quarter 2017 Financial Results
May 22, 2017 20:10 pm UTC| Business
BRISBANE, Calif., May 22, 2017 -- CareDx, Inc.(Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for...
CareDx Reports Preliminary First Quarter 2017 Financial Results
May 22, 2017 20:10 pm UTC| Business
BRISBANE, Calif., May 22, 2017 -- CareDx, Inc.(Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for...
CareDx Reports Preliminary First Quarter 2017 Financial Results
May 22, 2017 20:10 pm UTC| Business
BRISBANE, Calif., May 22, 2017 -- CareDx, Inc.(Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for...